$DARE News Article - Dar Bioscience Announces Achievement of First Commercial Milestone Under License Agreement for XACIATO(TM) (Clindamycin Phosphate) Vaginal Gel, 2%, FDA-Approved Treatment for Bacterial Vaginosis in Females 12 Years or Older
https://marketwirenews.com/news-releases/dar-...49003.html